Chat with us, powered by LiveChat

From talking to biotech companies and CROs, we know there's lots of confusion around eligibility when it come to the UK Government's R&D tax relief scheme.

Get it right and you have the basis of a potentially significant claim. Get it wrong, as a lot of life sciences companies do, and you could end up with a swarm of HMRC inspectors buzzing around your head.

As the UK's leading R&D tax relief specialist, let us share a few of the secrets to successful claims with you.


This applies to all biotech, but pharma in particular where the time taken to get first idea to market placement of a new drug can be enormous, along with the associated costs. For fear of over-claiming, traditional tax advisors typically take the 'safe' route of advising clients that the time spent at these very early stages isn't eligible, when in fact it is.


No one likes a research project to fail but from an R&D tax relief perspective, this is often a sign of eligibility. This applies to all areas of biotech, but especially animal breeding where the considerable time and effort devoted to genetic analysis of agriculturally important organisms or phenotypes doesn't always pay off, at least not in project terms. The good news is that the same technical difficulty that caused the project to fail could also form the basis of a significant claim.


If you're involved in pilot production, there are a few more things you should know. Diagnostic companies that produce pilot assay kits, reagents or solutions, for example, can't claim for lost production or opportunity costs, but can claim for the staff time, raw materials, subcontractors, software and utilities that go into the development and testing of these products. It's subtleties like this that can make all the difference between a successful claim and one that sparks an HMRC enquiry.


It doesn't matter how intricate or tailored the final result may be. Simply reconfiguring an existing IT package doesn't constitute R&D in the eyes of HMRC. Medical devices companies need to be especially wary of this, but it applies to the whole of the biotech sector.


The key point to take out of all these examples is that specialist knowledge is key. With a proven track record of making literally hundreds of successful claims for biotech and contract research organisations, Jumpstart represents a simple and effective way to boost much needed funding.

Isn't it time you joined other biotech and CROs in securing your share of R&D tax relief?

For a free R&D tax relief consultation and analysis of potential returns, contact us today!

Related Articles

jumpstart favicon

R&D tax credits – Whatever you do be sure to do this FIRST (or be sorry forever)

< Back to library We won’t lie to you, R&D tax credits can be a complicated business. Download our full guide For a start, HMRC’s CIRD (Corporate Intangibles Research and Development – rolls right off the tongue, doesn’t it!) guidelines run to 500 pages, which is enough to put anyone off! There is also a […]

29th June 2018
R&D Article
Please fill out your information below to get your PDF download.
Jumpstart white asterisk
Jumpstart your R&D tax credits…Call us on 0844 967 2626